Cardiovascular Manifestations of Hemochromatosis: A Review of Pathophysiology, Mechanisms, and Treatment Options

Shamim Ahmed1, Stephen J Peterson1,2, Manish A Parikh1,2

  • 1From the Department of Medicine, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY.

Cardiology in Review
|October 26, 2023
PubMed

Insights

Hemochromatosis, a genetic iron overload disorder, significantly impacts the cardiovascular system. This review details its cardiac complications, including heart failure and arrhythmias, emphasizing the need for awareness.

Area of Science:

  • Genetics and Medicine
  • Cardiology
  • Internal Medicine

Background:

  • Hemochromatosis is a common inherited disorder causing excessive iron absorption and organ deposition.
  • Iron overload can lead to severe damage in organs like the liver, heart, and pancreas.
  • Untreated hemochromatosis increases risks of cirrhosis, diabetes, heart failure, and cancer.

Purpose of the Study:

  • To review current literature on the pathogenesis of cardiovascular manifestations in hemochromatosis.
  • To detail the various cardiac complications associated with iron overload.
  • To elucidate the mechanisms underlying these cardiovascular issues.

Main Methods:

  • Comprehensive literature review of publicly available databases.
  • Analysis of studies focusing on hemochromatosis and cardiovascular disease.
  • Synthesis of information on pathogenesis and clinical manifestations.

Main Results:

  • Iron overload in hemochromatosis is a significant cause of cardiovascular morbidity and mortality.
  • Common cardiovascular manifestations include dilated cardiomyopathy, conduction abnormalities, and heart failure.
  • Other cardiac issues include cardiac fibrosis, myocardial infarction, and valvular heart disease.

Conclusions:

  • Hemochromatosis presents diverse and serious cardiovascular manifestations.
  • Understanding these cardiac effects is crucial for timely diagnosis and management.
  • Further research into the mechanisms can improve patient outcomes.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
73
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
12
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
15